C12N 2795/18033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2795/18033 (Use of viral protein as therapeutic agent other than vaccine) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 2
- Inventors
- 2
- Latest grant
- 11 Dec 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
By publication year.
Recent patents
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents11 Dec 2018US 10,151,762 B2Proclara Biosciences, Inc.
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents15 Nov 2016US 9,493,515 B2Proclara Biosciences, Inc.
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents15 Nov 2016US 9,493,516 B2Proclara Biosciences, Inc.
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents27 Apr 2017US 2017/0115311 A1Proclara Biosciences, Inc.
- Bacteriophage gene 3 protein compositions and use as amyloid binding agents14 Jan 2016US 2016/0009766 A1NeuroPhage Pharmaceuticals, Inc.
- Bacteriophage Gene 3 Protein Compositions and Use as Amyloid Binding Agents13 Nov 2014US 2014/0335016 A1NeuroPhage Pharmaceuticals, Inc.
Most cited
By later US patents